Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.9 USD | -3.65% | +3.57% | +75.76% |
Apr. 12 | Transcript : Generation Bio Co. - Special Call | |
Mar. 07 | Needham Cuts Price Target on Generation Bio to $10 From $14, Maintains Buy Rating | MT |
Business Summary
Number of employees: 174
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Genetic Medicines
100.0
%
| 0 | nan % | 6 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 6 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 17-09-30 | |
Matthew Norkunas
DFI | Director of Finance/CFO | 46 | 20-07-21 |
Antoinette Paone
COO | Chief Operating Officer | 46 | 18-09-30 |
Matthew Stanton
CTO | Chief Tech/Sci/R&D Officer | 51 | 17-09-30 |
Maren Killackey
IRC | Investor Relations Contact | - | - |
Yalonda Howze
LAW | General Counsel | 52 | 23-04-04 |
Phillip Samayoa
PRN | Corporate Officer/Principal | 37 | 18-11-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Jonas
BRD | Director/Board Member | 71 | 18-04-30 |
Director/Board Member | 76 | 17-11-30 | |
Jason Rhodes
FOU | Founder | 54 | 15-12-31 |
Charles Rowland
BRD | Director/Board Member | 65 | 18-07-30 |
Chief Executive Officer | 53 | 17-09-30 | |
Anthony Quinn
BRD | Director/Board Member | 62 | 17-11-30 |
Donald Nicholson
BRD | Director/Board Member | 67 | 17-11-30 |
Ronald Cooper
BRD | Director/Board Member | 61 | 21-02-28 |
Director/Board Member | 61 | 17-11-30 | |
Director/Board Member | 41 | 22-07-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 66,489,181 | 56,857,102 ( 85.51 %) | 0 | 85.51 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+75.76% | 193M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- GBIO Stock
- Company Generation Bio Co.